Clinical Trial Update: Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetic study comparing a 182 mg colon-targeted peppermint oil capsule with an enteric-coated peppermint oil capsule in irritable bowel syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Pain
• Irritable Bowel Syndrome

Drugs mentioned

• Tempocol (peppermint oil)
• Tempocol-ColoPulse (peppermint oil)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Irritable Bowel Syndrome, Abdominal Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-01-24